Autor: | Anita Dekker, De Wit Ineke, P. David Toman, R. Berg, Gerard Platenburg, Erika Platenburg, Naomi Sakai, Frank Pieper, Karatzas Costas N, Caroline Samuel, G. Daniels |
---|---|
Rok vydání: | 1999 |
Předmět: |
Genetically modified mouse
medicine.medical_specialty Transgene Structural gene Lysine Biology Molecular biology law.invention Procollagen peptidase Endocrinology law Internal medicine Gene expression Genetics Recombinant DNA medicine Animal Science and Zoology Agronomy and Crop Science Biotechnology Triple helix |
Zdroj: | Transgenic Research. 8:415-427 |
ISSN: | 0962-8819 |
DOI: | 10.1023/a:1008959924856 |
Popis: | The large scale production of recombinant collagen for use in biomaterials requires an efficient expression system capable of processing a large (>400 Kd) multisubunit protein requiring post-translational modifications. To investigate whether the mammary gland of transgenic animals fulfills these requirements, transgenic mice were generated containing the αS1-casein mammary gland-specific promoter operatively linked to 37 Kb of the human α1(I) procollagen structural gene and 3′ flanking region. The frequency of transgenic lines established was 12%. High levels of soluble triple helical homotrimeric [(α1)3] type I procollagen were detected (up to 8 mg/ml) exclusively in the milk of six out of 9 lines of lactating transgenic mice. The transgene-derived human procollagen chains underwent efficient assembly into a triple helical structure. Although proline or lysine hydroxylation has never been described for any milk protein, procollagen was detected with these post-translational modifications. The procollagen was stable in mil; minimal degradation was observed. These results show that the mammary gland is capable of expressing a large procollagen gene construct, efficiently assembling the individual polypeptide chains into a stable triple helix, and secreting the intact molecule into the milk. |
Databáze: | OpenAIRE |
Externí odkaz: |